Impact of prior authorization for oncology medications on practices with majority rural patient populations.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective cohort study shows prior authorization causes delays in cancer care for rural patients, highlighting inefficiencies.

All prior authorization submissions at rural practices were eventually approved, but delays were common, affecting patient care.
The analysis noted a total of 129 prior authorization submissions required over a three-month period, with substantial delays of up to 18 days observed.
This retrospective cohort study examined prior authorization impacts across three distinct community oncology practices in rural settings.
Findings suggest that current prior authorization processes introduce inefficient and avoidable delays for rural cancer patients.

Pritchett et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark